9.100
+0,00%
2026-10-15
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +48.7% | +170.5% | 3 / 3 | -0.4% | -1.41 pp | +2.15 pp | +23.4% | 0.34 | 3.06 | 282 | −0,4% | 16,1 | +59,6% | 3.06 | 5.30 | −42,2% |
| Pts | 8 | 12 | 12 | 0 | 4 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 9.100 (close price on 2026-10-15)EPS (TTM): 2.972
Financial charts
1.Revenue & growth
VND bn282Q2/26
1.Revenue & growth
VND bn282Q2/26
2.Profit & growth
VND bn15,6Q2/26
3.Profit mix (Penman)
VND bn36,9Q2/26
4.Margins & cost structure
%19.5%Q2/26
5.Returns & cash cycle
% · days27.7%Q2/26
6.Earnings quality & cash
VND bn76,3Q2/26
7.Asset structure
VND bn476Q2/26
8.Funding & debt health
VND bn · times476Q2/26
9.Revenue backlog
VND bn0,11Q2/26
10.Valuation
times · %3,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.483Q2/26
Adjusted EPS growth, latest quarter
48.7%
Average adjusted EPS growth, 3 quarters
48.7%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26